Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study

Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam

(2016) E. A. Reuland et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

(2016) Tat Ming Ng et al.   PLoS One

Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum  -Lactamase Bacteremia

(2015) P. D. Tamma et al.   CLINICAL INFECTIOUS DISEASES

The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae

(2015) Amy J. Mathers et al.   CLINICAL MICROBIOLOGY REVIEWS

Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae

(2015) Hadas Ofer-Friedman et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Mutagenesis of the CTX-M-type ESBL—is MIC-guided treatment according to the new EUCAST recommendations a safe approach?

(2015) João M. Costa Ramos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis

(2014) Hsih-Yeh Tsai et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Distribution of Extended-Spectrum β-Lactamases, AmpC β-Lactamases, and Carbapenemases among Enterobacteriaceae Isolates Causing Intra-Abdominal Infections in the Asia-Pacific Region: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

(2013) Wang-Huei Sheng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes

(2013) David van Duin et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy

(2013) Cheol-In Kang et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity

(2012) Kelvin K.W. To et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum  -lactamases: a systematic review and meta-analysis

(2012) K. Z. Vardakas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis

(2012) Wouter C. Rottier et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Piperacillin–tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

(2012) Cheol-In Kang et al.   JOURNAL OF INFECTION

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

(2011) N. Gupta et al.   CLINICAL INFECTIOUS DISEASES

Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases

(2011) Z.A. Qureshi et al.   CLINICAL MICROBIOLOGY AND INFECTION

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

Prevalence and clonality of extended-spectrum β-lactamases in Asia

(2008) P.M. Hawkey   CLINICAL MICROBIOLOGY AND INFECTION

Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam

(2008) L.R. Peterson   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe

(2008) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION